Month: October 2017

Apple fans may be miffed about the supply chain delays hitting the much-anticipated new iPhone X, but Apple investors don’t have much to worry about, according to a Wall Street analyst. “It’s certainly better than the alternative,” meaning lower demand, Andy Hargreaves, an analyst at KeyBanc, told CNBC’s Power Lunch on Friday. Pre-orders for Apple’s
0 Comments
The news roiled pharmaceutical stocks, while Amazon shares are at all-time highs. According to Tanquilut, Amazon’s business-to-business medical device web page was posted during the same period the company was granted wholesale distribution licenses in several states. The licensure was first reported by the St. Louis Post-Dispatch. An Amazon spokesperson previously told CNBC by email
0 Comments
Expedia CEO Mark Okerstrom told CNBC that the company’s stock decline on Friday is a “concern” but he is still “incredibly optimistic” about the future of the business. Shares of the travel company fell Friday, one day after it reported quarterly earnings that failed to meet Wall Street’s expectations. The stock was down about 18
0 Comments
Merck reported profit ahead of Street estimates on strong sales of its cancer drug Keytruda but total revenue fell in the quarter from disruptions due to the NotPetya cyber attack and loss of market share for many of its older drugs. Sales of Keytruda more than doubled to $1.05 billion in the third quarter but
0 Comments